Clinical Trials on 直肠黏液腺癌 in China
总计637个结果
-
Fang WuXiangya Hospital of Central South University; Hunan Cancer Hospital; The Third Xiangya Hospital...招聘中
-
Tianjin Medical University General HospitalShehzaad Joomye; Haiyun Wang; Donglai Yan未知术中右美托咪定对顺阿曲库铵输注用量及其恢复指标的影响。 | 右美托咪定对舒芬太尼消耗的影响。 | 不同年龄组顺阿曲库铵输注量、舒芬太尼用量及恢复指数定量分析。中国
-
Sun Yat-sen University招聘中
-
National Cancer Institute (NCI)NRG Oncology主动,不招人复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 卵巢子宫内膜样腺癌 | 卵巢浆液性癌 | 卵巢未分化癌 | 卵巢透明细胞腺癌 | 输卵管移行细胞癌 | 黏液腺癌 | 卵巢移行细胞癌 | 输卵管透明细胞腺癌 | 输卵管子宫内膜样腺癌 | 输卵管粘液腺癌 | 输卵管浆液性腺癌 | 输卵管未分化癌 | 卵巢浆液性腺癌 | 原发性腹膜浆液性腺癌 | 原发性腹膜透明细胞腺癌 | 原发性腹膜移行细胞癌 | 原发性腹膜未分化癌 | 原发性腹膜子宫内膜样腺癌 | 卵巢布伦纳瘤 | 卵巢透明细胞腺癌纤维瘤 | 透明细胞腺癌 | 未分化癌美国, 大韩民国, 日本
-
Chinese PLA General Hospital未知Evaluate the Safety and Effectiveness of Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Donor Sites中国
-
The First Affiliated Hospital with Nanjing Medical...The First Affiliated Hospital of Soochow University招聘中
-
Hunan Province Tumor Hospital尚未招聘
-
Peking University People's Hospital未知
-
Merck KGaA, Darmstadt, Germany完全的
-
Novartis Pharmaceuticals完全的
-
The First Affiliated Hospital of Xiamen University未知
-
Shanghai Junshi Bioscience Co., Ltd.主动,不招人
-
Fudan UniversityHarbin Medical University; Liaoning Tumor Hospital & Institute未知
-
Shandong University完全的the Incidence of Gastrointestinal Diseases Diagnosed by Endoscopy in Physicians and General Population中国
-
European Organisation for Research and Treatment...Japan Clinical Oncology Group; European Society of Surgical Oncology完全的
-
Liaoning Tumor Hospital & Institute尚未招聘
-
Sichuan Provincial People's Hospital终止
-
Hui Lin未知Lung Adenocarcinoma Patients With Postoperative in pN2中国
-
Second Affiliated Hospital of Wenzhou Medical UniversityBeijing Jishuitan Hospital完全的
-
Hecheng Li M.D., Ph.DSecond Affiliated Hospital, School of Medicine, Zhejiang University; Ruijin Hospital; Shanghai... 和其他合作者完全的
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and Prevention完全的
-
Li Zhang, MD招聘中诊断为 ALK 阳性 NSCLC | 第二代 ALK-TKI 耐药 | Ensatinib 在这部分患者中的疗效中国
-
Third Military Medical University未知